IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS
(2008) 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases In Hepatology 48(4). p.1875-1875
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1305616
- author
- Dalgard, Olav ; Verbaan, Hans LU ; Ring-Larsen, Helmer and Bjoro, Kristian
- organization
- publishing date
- 2008
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Hepatology
- volume
- 48
- issue
- 4
- pages
- 1875 - 1875
- publisher
- John Wiley & Sons Inc.
- conference name
- 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
- conference dates
- 2008-10-31 - 2008-11-04
- external identifiers
-
- wos:000259757402551
- ISSN
- 1527-3350
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)
- id
- 77060d0e-ca9e-4e3b-bc3b-b6ecfce44f41 (old id 1305616)
- date added to LUP
- 2016-04-01 14:53:22
- date last changed
- 2018-11-21 20:31:12
@misc{77060d0e-ca9e-4e3b-bc3b-b6ecfce44f41, author = {{Dalgard, Olav and Verbaan, Hans and Ring-Larsen, Helmer and Bjoro, Kristian}}, issn = {{1527-3350}}, language = {{eng}}, note = {{Conference Abstract}}, number = {{4}}, pages = {{1875--1875}}, publisher = {{John Wiley & Sons Inc.}}, series = {{Hepatology}}, title = {{IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS}}, volume = {{48}}, year = {{2008}}, }